Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012)

Achieve Life Sciences' (ACHV) quarterly Operating Margin came in at 126.18% in Q3 2012, down 22280.0% YoY from N/an in Q4 2011, and down 48.44% on a QoQ basis from 244.71% in Q2 2012.

Analysis

Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012) Analysis & Trends

Achieve Life Sciences (ACHV) has 3 years of Operating Margin data on file, last reported at 126.18% in Q3 2012.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 30.15%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 32.54%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -562.07%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.06%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 17.93%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.75%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.36%
10 Achieve Life Sciences 369.90 Mn 369.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 126.18%
Jun 30, 2012 244.71%
Mar 31, 2012 -418.16%
Sep 30, 2011 348.98%
Jun 30, 2011 264.60%
Mar 31, 2011 -435.78%
Sep 30, 2010 -142.33%
Jun 30, 2010 -167.72%